Thuja et al. invest €2.4m in Therasolve

Thuja is an existing investor in the company alongside LRM, a Limburg-focused investment company. The two firms first invested in Therasolve in August 2011.

Thuja and LRM were joined in the round by Ark Angels Activator Fund and Business Angels of BAN Vlaanderen, which are collectively supplying €900,000 towards the round.

Therasolve will use the fresh capital to aid in the development and commercialisation of its MemoPatch product.

Company
Founded in 2009 and headquartered in Diepenbeek, Therasolve is a developer of medical skin patches. The company has developed the MemoPatch, which is designed to remind patients to take their medication on time.

People
Wim De Geest is the CEO of Therasolve. Thuja managing partner Harrold van Barlingen is chairman of the company's board. LRM investment manager Debora Dumont sits on the board.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Early-stage
• Healthcare
• Belgium